[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-460046-105":59,"doc-detail-460046-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","comparative-analysis-of-microrna-expression-in-serum-and-plasma-in-patients-screened-for-brca1-or-brca2-mutations","Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations","","MicroRNA-based biomarkers offer promise for precision oncology, yet clinical translation is hindered by lack of standardization and pre-analytical variability. This technical study evaluates how biological material (plasma vs serum) and quantification approach (miRNA-seq vs RT-qPCR) influence circulating miRNA levels. Samples from 202 women, including BRCA1/2 pathogenic variant carriers from three centers, were profiled using sequencing, qPCR, or targeted qPCR. Results show stronger serum–plasma differences with sequencing than with qPCR, while measurement correlations are significant for about 75% of miRNAs. qPCR and sequencing also display strong agreement for a hemolysis marker, supporting cross-platform use. Calibration remains material-specific to enable reliable test conversion and biomarker selection.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparative-analysis-of-microrna-expression-in-serum-and-plasma-in-patients-screened-for-brca1-or-brca2-mutations/460046/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparative-analysis-of-microrna-expression-in-serum-and-plasma-in-patients-screened-for-brca1-or-brca2-mutations/460046.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of this technical study?","Question",{"text":112,"@type":113},"To determine how serum versus plasma and miRNA-seq versus RT-qPCR affect circulating microRNA levels in patients screened for BRCA1 or BRCA2 mutations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were miRNAs quantified in the study?",{"text":117,"@type":113},"MiRNAs were measured using miRNA sequencing (miRNA-seq), a qPCR panel of 182 miRNAs, or targeted qPCR for 13 BRCA mutation- or ovarian cancer-associated miRNAs.",{"name":119,"@type":110,"acceptedAnswer":120},"Did serum and plasma show the same miRNA results across methods?",{"text":121,"@type":113},"Concordance was generally good for high-expression miRNAs, but serum–plasma differences were more pronounced with sequencing than with qPCR; converting multi-miRNA tests between materials is not feasible without calibration.",{"name":123,"@type":110,"acceptedAnswer":124},"Which marker supported agreement between sequencing and qPCR?",{"text":125,"@type":113},"A qPCR hemolysis marker based on miR-451a and miR-23a-3p showed strong inter-assay correlation, providing evidence it can be used in sequencing data as well.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},460046,1790939482,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Smyczynska etal. Biomarker Research (2026) 14:9 Biomarker Research  \n[https://doi.org/10.1186/s40364-025-00882-z](https://doi.org/10.1186/s40364-025-00882-z)  \nCORRESPONDENCE Open Access  \nComparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations  \nUrszula Smyczynska 1, Aleksander Rycerz 1, Klaudia Kozlowska 1, Heather Symecko2, Jamie Brower2, Susan M. Domchek2, Kevin Elias3, Panagiotis Konstantinopoulos4, Sophia Apostolidou5, Usha Menon5, Wojciech Fendler 1,4,6* and Dipanjan Chowdhury4,7,8*  \nAbstract  \nMicroRNA-based biomarkers hold promise for precision oncology, but standardization and pre-analytical variability remain barriers to clinical use. We performed a technical study to assess how the type of biological material (plasma, serum) and quantification (miRNA-seq, RT-qPCR) method affect microRNA (miRNA) levels. Samples from 202 women – 154 carriers of BRCA1/2 pathogenic variants, from three centers were collected. MiRNAs were quantified using miRNA sequencing (miRNA-seq), a quantitative PCR (qPCR) panel of 182 miRNAs (Qiagen) or targeted qPCR of 13 miRNA associated with BRCA mutations or ovarian cancer. Differential expression and linear regression analyses were used to assess methods concordance and biological material-related differences. Differences of individual miRNA levels between serum and plasma were more pronounced in sequencing than in qPCR. miR-193a-3p, miR-197-3p, miR-877-5p and miR-2110 were detected in significantly higher amounts in serum, while miR-28-5p in plasma, by both sequencing and qPCR. Measurements done by sequencing and qPCR correlated positively and significantly for ~ 75% of investigated miRNA. Finally, strong inter-assay correlation of established qPCR hemolysis marker (based on miR-451a and miR-23a-3p) provided evidence that it can be used also in sequencing data. Differences in absolute and relative miRNA levels in serum and plasma necessitate material-specific test calibration and may impact selection of best miRNA biomarkers for specific scenarios.  \nConcordance in expression levels quantified by miRNA-seq and qPCR is generally good for high-expression miRNAsin both serum and plasma, but a conversion of multi-miRNA tests from serum to plasma is unfeasible without experimental calibration.  \nKeywords microRNA biomarkers, Plasma vs serum, BRCA mutations  \n*Correspondence:  \nWojciech Fendler [Wojciech.fendler@umed.lodz.pl](Wojciech.fendler@umed.lodz.pl)[ ](Wojciech.fendler@umed.lodz.pl)Dipanjan Chowdhury [Dipanjan_chowdhury@dfci.harvard.edu](Dipanjan_chowdhury@dfci.harvard.edu)  \n1Department of Biostatistics and Translational Medicine, Medical University of Lodz, Mazowiecka 15, Lodz 92-215, Poland  \n2Basser Center for BRCA, Perel man School of Medicine, University of Pennsylvania, Philadelphia, PA, USA  \n3Section of Gynecologic Oncology, Obstetrics and Gynecology Institute, Lerner Research Institute, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA  \n4Department of Radiation Oncology, Dana-Farber Cancer Institute, 4 Blackfan circle 02215, Boston, MA, USA  \n5MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK  \n6Medical Research Agency, Warsaw, Poland  \n7Harvard Medical School, Boston, MA, USA  \n8Broad Institute, Cambridge, MA, USA  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the artic","cbCaipZ8F5BiZUaq","https://ap.wps.com/l/cbCaipZ8F5BiZUaq","pdf",2546912,"English","# Abstract\n# Correspondence\n# Translation to clinical practice\n## Study focus on biomaterial and quantification methods\n## Datasets and sample sources\n## Study methodology references","[{\"question\":\"What was the main goal of this technical study?\",\"answer\":\"To determine how serum versus plasma and miRNA-seq versus RT-qPCR affect circulating microRNA levels in patients screened for BRCA1 or BRCA2 mutations.\"},{\"question\":\"How were miRNAs quantified in the study?\",\"answer\":\"MiRNAs were measured using miRNA sequencing (miRNA-seq), a qPCR panel of 182 miRNAs, or targeted qPCR for 13 BRCA mutation- or ovarian cancer-associated miRNAs.\"},{\"question\":\"Did serum and plasma show the same miRNA results across methods?\",\"answer\":\"Concordance was generally good for high-expression miRNAs, but serum–plasma differences were more pronounced with sequencing than with qPCR; converting multi-miRNA tests between materials is not feasible without calibration.\"},{\"question\":\"Which marker supported agreement between sequencing and qPCR?\",\"answer\":\"A qPCR hemolysis marker based on miR-451a and miR-23a-3p showed strong inter-assay correlation, providing evidence it can be used in sequencing data as well.\"}]","Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations | PDF",1790757583,13,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/50f6a44ad54d7c3c79a589d0900a39b9.webp",983,1310,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/5b2721b1d91c07d9a81089e6ebda166a.webp",982,1309,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/1f1a01ff2cea49eabc1900418403b1b5.webp",981,1308,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/246efff7974490f45aae5a3a22971374.webp",980,1306]